Form 4 for NTRA Natera, Inc.
Accepted 2025-11-03 00:00:00 ET · period of report 2025-11-03 · accession 0001711968-25-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-03 | 2025-11-03 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | $116.02 | +155.7K | 151.9K | New | +$18.06M |
| DM | 2025-11-03 | 2025-11-03 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | S - Sale+OE | $199.96 | -160.7K | 303.3K | -35% | -$32.13M |
| DM | 2025-11-03 | 2025-11-03 | NTRA | Chapman Steven Leonard | CEO AND Pres, Dir | M - OptEx | $0.00 | -155.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-03 | M | A | 150,000 | $119.75 | 305,519 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-03 | M | A | 3,595 | $20.27 | 155,519 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-03 | M | A | 2,084 | $13.01 | 151,924 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-03 | S | D | 156,573 | $200.00 | 144,816 | D | — | — | (F1) The sale of shares on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024. The sale of 150,000 of these shares was governed by the initial plan and not altered by the subsequently amendment. (F4) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.51 to $200.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2025-11-03 | S | D | 1,915 | $198.96 | 301,389 | D | — | — | (F1) The sale of shares on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024. The sale of 150,000 of these shares was governed by the initial plan and not altered by the subsequently amendment. (F3) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.44 to $199.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2025-11-03 | S | D | 2,215 | $198.03 | 303,304 | D | — | — | (F1) The sale of shares on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023, as amended on December 2, 2024. The sale of 150,000 of these shares was governed by the initial plan and not altered by the subsequently amendment. (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.28 to $198.27 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Derivative | Stock Option (right to buy) | 2025-11-03 | M | D | 2,084 | $0.00 | 0 | D | $13.01 · — to 2029-01-10 | 2,084 Common Stock | (F5) The option shares are fully exercisable. |
| 8 | Derivative | Stock Option (right to buy) | 2025-11-03 | M | D | 3,595 | $0.00 | 0 | D | $20.27 · — to 2029-04-11 | 3,595 Common Stock | (F5) The option shares are fully exercisable. |
| 9 | Derivative | Stock Option (right to buy) | 2025-11-03 | M | D | 150,000 | $0.00 | 0 | D | $119.75 · — to 2031-01-21 | 150,000 Common Stock | (F6) On January 22, 2021, the Reporting Person was granted performance-based options which vest in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. The performance thresholds were certified on June 28, 2024, March 28, 2025 and September 28, 2025, resulting in the performance-based option being fully vested as of the last performance threshold date. |